SmileDirectClub (SDCCQ) Competitors

SDCCQ vs. LYRA, GCTK, XAGE, SSKN, and DYNT

Should you buy SmileDirectClub stock or one of its competitors? MarketBeat compares SmileDirectClub with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SmileDirectClub include Lyra Therapeutics (LYRA), GlucoTrack (GCTK), Longevity Health (XAGE), Strata Skin Sciences (SSKN), and Dynatronics (DYNT). These companies are all part of the "medical equipment" industry.

How does SmileDirectClub compare to Lyra Therapeutics?

Lyra Therapeutics (NASDAQ:LYRA) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

95.6% of Lyra Therapeutics shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 3.3% of Lyra Therapeutics shares are owned by insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

SmileDirectClub has higher revenue and earnings than Lyra Therapeutics. Lyra Therapeutics is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lyra Therapeutics	$600K	2.22	-$93.43M	-$19.15	N/A
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A

In the previous week, Lyra Therapeutics' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company	Overall Sentiment
Lyra Therapeutics	Neutral
SmileDirectClub	Neutral

Lyra Therapeutics has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to Lyra Therapeutics' net margin of -5,491.17%. SmileDirectClub's return on equity of 0.00% beat Lyra Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lyra Therapeutics	-5,491.17%	-1,010.91%	-58.92%
SmileDirectClub	N/A	N/A	N/A

Given SmileDirectClub's higher probable upside, analysts clearly believe SmileDirectClub is more favorable than Lyra Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lyra Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

SmileDirectClub beats Lyra Therapeutics on 10 of the 12 factors compared between the two stocks.

How does SmileDirectClub compare to GlucoTrack?

SmileDirectClub (NASDAQ:SDCCQ) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled GlucoTrack'saverage media sentiment score.

Company	Overall Sentiment
SmileDirectClub	Neutral
GlucoTrack	Neutral

SmileDirectClub has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market. Comparatively, GlucoTrack has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 2.2% of GlucoTrack shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Given SmileDirectClub's higher possible upside, analysts clearly believe SmileDirectClub is more favorable than GlucoTrack.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
GlucoTrack	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SmileDirectClub's return on equity of 0.00% beat GlucoTrack's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SmileDirectClub	N/A	N/A	N/A
GlucoTrack	N/A	-581.98%	-220.10%

GlucoTrack has lower revenue, but higher earnings than SmileDirectClub. GlucoTrack is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A
GlucoTrack	N/A	N/A	-$19.39M	-$18.04	N/A

Summary

SmileDirectClub beats GlucoTrack on 8 of the 11 factors compared between the two stocks.

How does SmileDirectClub compare to Longevity Health?

SmileDirectClub (NASDAQ:SDCCQ) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

SmileDirectClub has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market. Comparatively, Longevity Health has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

Longevity Health has lower revenue, but higher earnings than SmileDirectClub. Longevity Health is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A
Longevity Health	$1.05M	0.51	-$10.37M	-$4.29	N/A

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Longevity Health'saverage media sentiment score.

Company	Overall Sentiment
SmileDirectClub	Neutral
Longevity Health	Neutral

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 24.2% of Longevity Health shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 29.0% of Longevity Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

SmileDirectClub has a net margin of 0.00% compared to Longevity Health's net margin of -682.67%.

Company	Net Margins	Return on Equity	Return on Assets
SmileDirectClub	N/A	N/A	N/A
Longevity Health	-682.67%	N/A	-261.90%

Summary

SmileDirectClub beats Longevity Health on 7 of the 9 factors compared between the two stocks.

How does SmileDirectClub compare to Strata Skin Sciences?

SmileDirectClub (NASDAQ:SDCCQ) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

Given SmileDirectClub's higher probable upside, analysts clearly believe SmileDirectClub is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

SmileDirectClub has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SmileDirectClub's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SmileDirectClub	N/A	N/A	N/A
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

SmileDirectClub has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, suggesting that its share price is 105% less volatile than the broader market.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
SmileDirectClub	Neutral
Strata Skin Sciences	Neutral

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Strata Skin Sciences has lower revenue, but higher earnings than SmileDirectClub. Strata Skin Sciences is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

Summary

SmileDirectClub beats Strata Skin Sciences on 9 of the 12 factors compared between the two stocks.

How does SmileDirectClub compare to Dynatronics?

SmileDirectClub (NASDAQ:SDCCQ) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company	Overall Sentiment
SmileDirectClub	Neutral
Dynatronics	Neutral

SmileDirectClub has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

Dynatronics has lower revenue, but higher earnings than SmileDirectClub.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.29	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

SmileDirectClub has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. SmileDirectClub's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SmileDirectClub	N/A	N/A	N/A
Dynatronics	-8.35%	-41.81%	-9.56%

Summary

SmileDirectClub beats Dynatronics on 8 of the 10 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SDCCQ vs. The Competition

Export

Metric	SmileDirectClub	Dental equipment & supplies Industry	Medical Sector	NASDAQ Exchange
Market Cap	$40K	$2.91M	$6.46B	$12.34B
Dividend Yield	N/A	N/A	2.76%	5.28%
P/E Ratio	0.00	N/A	21.22	25.66
Price / Sales	N/A	0.07	562.28	86.31
Price / Cash	N/A	N/A	43.49	56.67
Price / Book	N/A	0.01	10.31	7.14
Net Income	-$86.40M	-$60.92M	$3.57B	$335.98M

SmileDirectClub Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SDCCQ SmileDirectClub	N/A	N/A	N/A	N/A	$40K	$470.74M	N/A	2,700
LYRA Lyra Therapeutics	0.2956 of 5 stars	$0.65 -7.1%	N/A	-83.7%	$1.15M	$600K	N/A	50
GCTK GlucoTrack	0.085 of 5 stars	$0.48 -25.7%	N/A	-93.7%	$937K	N/A	N/A	5
XAGE Longevity Health	N/A	$0.46 flat	N/A	N/A	$820K	$1.05M	N/A	14	Gap Up
SSKN Strata Skin Sciences	0.2157 of 5 stars	$0.12 -6.2%	N/A	-94.2%	$718K	$30.98M	N/A	120	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SmileDirectClub (SDCCQ) Competitors

SDCCQ vs. LYRA, GCTK, XAGE, SSKN, and DYNT

How does SmileDirectClub compare to Lyra Therapeutics?

Summary

How does SmileDirectClub compare to GlucoTrack?

Summary

How does SmileDirectClub compare to Longevity Health?

Summary

How does SmileDirectClub compare to Strata Skin Sciences?

Summary

How does SmileDirectClub compare to Dynatronics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDCCQ vs. The Competition

SmileDirectClub Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SmileDirectClub (SDCCQ) Competitors

SDCCQ vs. LYRA, GCTK, XAGE, SSKN, and DYNT

How does SmileDirectClub compare to Lyra Therapeutics?

Do insiders & institutionals hold more shares of LYRA or SDCCQ?

Which has higher earnings & valuation, LYRA or SDCCQ?

Does the media refer more to LYRA or SDCCQ?

Which has more risk & volatility, LYRA or SDCCQ?

Is LYRA or SDCCQ more profitable?

Do analysts rate LYRA or SDCCQ?

Summary

How does SmileDirectClub compare to GlucoTrack?

Does the media favor SDCCQ or GCTK?

Which has more risk and volatility, SDCCQ or GCTK?

Do insiders & institutionals have more ownership in SDCCQ or GCTK?

Do analysts prefer SDCCQ or GCTK?

Is SDCCQ or GCTK more profitable?

Which has better valuation and earnings, SDCCQ or GCTK?

Summary

How does SmileDirectClub compare to Longevity Health?

Which has more risk and volatility, SDCCQ or XAGE?

Which has stronger valuation & earnings, SDCCQ or XAGE?

Does the media prefer SDCCQ or XAGE?

Do institutionals & insiders have more ownership in SDCCQ or XAGE?

Is SDCCQ or XAGE more profitable?

Summary

How does SmileDirectClub compare to Strata Skin Sciences?

Do analysts prefer SDCCQ or SSKN?

Is SDCCQ or SSKN more profitable?

Which has more volatility & risk, SDCCQ or SSKN?

Does the media prefer SDCCQ or SSKN?

Do insiders & institutionals believe in SDCCQ or SSKN?

Which has higher earnings & valuation, SDCCQ or SSKN?

Summary

How does SmileDirectClub compare to Dynatronics?

Do insiders & institutionals believe in SDCCQ or DYNT?

Does the media prefer SDCCQ or DYNT?

Which has more risk & volatility, SDCCQ or DYNT?

Which has better valuation and earnings, SDCCQ or DYNT?

Is SDCCQ or DYNT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDCCQ vs. The Competition

SmileDirectClub Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools